Samuel Blackman

Samuel Blackman is a highly accomplished professional in the biopharmaceutical industry with extensive experience in research and development, clinical development, and strategic oversight. Currently serving as the Founder and Head of Research and Development and Chief Medical Officer at Day One Biopharmaceuticals, Samuel also holds board and advisory roles at Presage Biosciences, Inc., Notable, and Litmus Health. Previous leadership positions include Head of Clinical Development at Mavupharma, Senior Vice President at Silverback Therapeutics, and Senior Medical Director at Juno Therapeutics, among others. Samuel's educational background includes an MD and PhD from the University of Illinois College of Medicine and a BA from the University of Chicago.